Hypertyraminemia in Cirrhotic Patients

New England Journal of Medicine

Volumn 294, Issue 25, 1976, Pages 1360-1364

  Faraj, Bahjat A ^a   Bowen, Paul A ^a   Isaacs, James W ^a   Rudman, Daniel ^a   Camp, Vernon M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TYRAMINE; TYROSINE;

BRAIN DISEASE; DIAGNOSIS; ETIOLOGY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METHODOLOGY;

EID: 0017072893     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197606172942502     Document Type: Article

References (37)

1. Melnykowycz J, Johansson KR: Formation of amines by intestinal microorganisms and the influence of chlortetracycline. J Exp Med 101: 507–517, 1955
2. David J-C, Dairman W, Udenfriend S: Decarboxylation to tyramine: a major route of tyrosine metabolism in mammals. Proc Natl Acad Sci USA 71: 1771–1775, 1974
3. David: On the importance of decarboxylation in the metabolism of phenylalanine, tyrosine and tryptophan. Arch Biochem Biophys 160: 561–568, 1974
4. Asatoor AM, Kerr DNS: Amines in blood and urine in relation to liver disease. Clin Chim Acta 6: 149–156, 1961
5. Fazekas JF, Ticktin HE, Ehrmantraut WR, et al: Cerebral metabolism in hepatic insufficiency. Am J Med 21: 843–849, 1956
6. Wechsler RL, Crum W, Roth JLA: The blood flow and O2 consumption of the human brain in hepatic coma. Clin Res Proc 2: 74, 1954
7. Fischer JE, Baldessarini RJ: False neurotransmitters and hepatic failure. Lancet 2: 75–80, 1971
8. Lam KC, Tall AR, Goldstein GB, et al: Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy. Scand J Gastroenterol 8: 465–472, 1973
9. Manghani KK, Lunzer MR, Billing BH, et al: Urinary and serum octopamine in patients with portal–systemic encephalopathy. Lancet 2: 943–946, 1975
10. Molinoff PB, Landsberg L, Axelrod J: An enzymatic assay for octopamine and other β-hydroxylated phenylethylamines. J Pharmacol Exp Ther 170: 253–261, 1969
11. Faraj BA, Mu JY, Lewis MS, et al: Determination of plasma and tissue levels of tyramine by radioimmunoassay. Proc Soc Exp Biol Med 149: 664–669, 1975
12. Parsons-Smith BG, Summerskill WHJ, Dawson AM, et al: The electroencephalograph in liver disease. Lancet 2: 867–871, 1957
13. Blackburn S: Amino Acid Determination: Methods and techniques. New York, Marcel Dekker, Incorporated, 1968
14. Forman DT: Rapid determination of plasma ammonia by an ion-exchange technic. Clin Chem 10: 497–508, 1964
15. Schayer RW: In vivo inhibition of monoamine oxidase studied with radioactive tyramine. Proc Soc Exp Biol Med 84: 60–63, 1953
16. Horwitz D, Lovenberg W, Engelman K, et al: Monoamine oxidase inhibitors, tyramine, and cheese. JAMA 188: 1108–1110, 1964
17. Bhansali KG, Lach JL, Clifton JA: MAO activity in normal, cirrhotic, and noncirrhotic abnormal human liver. J Pharm Sci 60: 611–613, 1971
18. Levine RJ, Conn HO: Tyrosine metabolism in patients with liver disease. J Clin Invest 46: 2012–2020, 1967
19. Fischer JE, Yoshimura N, Aguirre A, et al: Plasma amino acids in patients with hepatic encephalopathy: effects of amino acid infusions. Am J Surg 127: 40–47, 1974
20. Knox WE: Metabolism of phenylalanine and tyrosine, Symposium on Amino Acid Metabolism, Johns Hopkins University, 1954 (Johns Hopkins University McCollum-Pratt Institute Contribution No. 105). Edited by WD McElroy, HB Glass. Baltimore, Johns Hopkins University Press, 1955, pp 836–866
21. Burn JH, Rand MJ: The action of sympathomimetic amines in animals treated with reserpine. J Physiol 144: 314–336, 1958
22. Furchgott RF, Kirpekar SM, Rieker M, et al: Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J Pharmacol Exp Ther 142: 39–58, 1963
23. McNeill JH, Brody TM: The effect of various drug pretreatments on amine-induced phosphorylase activation and amine uptake. J Pharmacol Exp Ther 162: 121–133, 1968
24. Neff NH, Tozer TN, Hammer W, et al: Kinetics of release of norepinephrine by tyramine. Life Sci 4: 1869–1875, 1965
25. Weiner N, Selvaratnam I: The effect of tyramine on the synthesis of norepinephrine. J Pharmacol Exp Ther 161: 21–33, 1968
26. Blackwell B, Marley E: Interactions of cheese and its constituents with monoamine oxidase inhibitors. Br J Pharmacol 26: 120–141, 1966
27. Mashford ML, Mahon WA, Chalmers TC: Studies of the cardiovascular system in the hypotension of liver failure. N Engl J Med 267: 1071–1074, 1962
28. Cohen RA, Kopin IJ, Creveling CR, et al: False neurochemical transmitters: combined clinical staff conference at the National Institutes of Health. Ann Intern Med 65: 347–362, 1966
29. Baldessarini RJ, Vogt M: The uptake and subcellular distribution of aromatic amines in the brain of the rat. J Neurochem 18: 2519–2533, 1971
30. Baldessarini RJ: Release of aromatic amines from brain tissues of the rat in vitro. J Neurochem 18: 2509–2518, 1971
31. Dodsworth JM, James JH, Cummings MC, et al: Depletion of brain norepinephrine in acute hepatic coma. Surgery 75: 811–820, 1974
32. Fischer JE: False neurotransmitters and hepatic coma. Res Publ Assoc Res Nerv Ment Dis 53: 53–73, 1974
33. Oldendorf WH: Brain uptake of Radio-labeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221: 1629–1639, 1971
34. Mattson WJ Jr, Iob V, Sloan M, et al: Alterations of individual free amino acids in brain during acute hepatic coma. Surg Gynecol Obstet 130: 263–266, 1970
35. Müting D, Dishuk BD: Free amino acids in serum, cerebrospinal fluid, and urine in renal disease with and without uremia. Proc Soc Exp Biol Med 126: 754–758, 1967
36. Pollay M: Transport mechanisms in the choroid plexus. Fed Proc 33: 2064–2069, 1974
37. Brandau K, Axelrod J: Ring dehydroxylation and N-methylation of noradrenaline and dopamine in the intact rat brain. Frontiers in Catecholamine Research: Proceedings of the Third International Catecholamine Symposium held at the University of Strasbourg, Strasbourg, France, May 20–25, 1973. Edited by E Usdin, SH Snyder. New York, Pergamon Press, 1973, pp 129–131